View |
|
BR-041-03
|
Enoxaparin Sodium
|
Enoxbicare-40
|
4000 IU Anti-Factor Xa (equivalent to 40 mg) / 0.4 mL
|
Solution For Injection (SC)
|
-
|
Brawn Laboratories Ltd.
|
India
|
Initial (Revalidation)
|
25 April 2022
|
09 December 2025
|
View |
|
BR-088
|
Enoxaparin Sodium
|
Hepaclex
|
60 mg/0.6 mL
|
Solution for Injection (SC)
|
Antithrombotic Agents
|
Gland Pharma Limited
|
India
|
Renewal
|
07 March 2024
|
04 June 2028
|
View |
|
BR-1000
|
Japanese Encephalitis Virus (Live, Attenuated)
|
Imojev
|
Formulation: After reconstitution, one dose (0.5 mL) contains 4.0-5.8 log Plaque Forming Units (PFU) live, attenuated, recombinant Japanese Encephalitis Virus.
|
Powder for Suspension for Injection (SC)
|
-
|
Government Pharmaceutical Organization - Merieux Biological Products Co., Ltd.
|
Thailand
|
Initial (Variation)
|
13 July 2022
|
13 July 2027
|
View |
|
BR-1001
|
Phospholipid Fraction from Bovine Lung
|
Alveofact
|
45 mg/mL (54 mg/1.2 mL)
|
Lyophilized Powder for
Suspension for Intratracheal Administration
|
-
|
BAG Health Care GmbH
|
Germany
|
-
|
11 May 2021
|
06 January 2025
|
View |
|
BR-1002
|
Insulin Human (rDNA)
|
Insuget-N
|
100 IU/mL
|
Suspension for Injection (IM/SC)
|
Insulins and Analogues
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
Renewal
|
22 October 2020
|
06 January 2025
|
View |
|
BR-1004
|
Heparin Sodium
|
Heparin Leo
|
1,000 IU/mL
|
Solution For Injection (IV/SC)
|
Anticoagulant
|
Leo Pharma A/S
|
Denmark
|
Automatic Renewal (Variation)
|
09 March 2023
|
09 March 2028
|
View |
|
BR-1005
|
Heparin Sodium
|
Heparin Leo
|
5,000 IU/mL
|
Solution For Injection (IV/SC)
|
Antithrombotic Agents
|
Leo Pharma A/S
|
Denmark
|
Initial (Variation)
|
23 March 2023
|
23 March 2028
|
View |
|
BR-1008
|
Human Insulin (rDNA)
|
Actrapid
|
100 IU/mL
|
Solution For Injection (Im/Iv/Sc)
|
Antidiabetic
|
Novo Nordisk A/S
|
Denmark
|
Renewal
|
05 April 2024
|
06 May 2029
|
View |
|
BR-1009
|
Insulin Human
|
Insulatard Flexpen
|
100 U/mL
|
Suspension For Injection (SC)
|
-
|
Novo Nordisk A/S
|
Denmark
|
Regular Renewal
|
08 March 2021
|
13 August 2025
|
View |
|
BR-1010
|
Isophane Insulin Human, Recombinant DNA
|
Insulatard
|
100 IU/mL
|
Suspension For Injection
|
Intermediate-acting Insulin
|
Novo Nordisk A/S
|
Denmark
|
Renewal
|
02 August 2023
|
20 August 2028
|
View |
|
BR-1011
|
Insulin Detemir
|
Levemir FlexPen
|
100 U/ mL
|
Solution for injection
|
Antidiabetic
|
Novo Nordisk A/S
|
Denmark
|
Automatic Renewal
|
03 February 2022
|
22 December 2026
|
View |
|
BR-1012
|
Insulin Human
|
Mixtard 30 FlexPen
|
100 IU/mL (Soluble Insulin 30% and Isophane Insulin 70%)
|
Suspension For Injection (SC)
|
-
|
Novo Nordisk A/S
|
Denmark
|
-
|
08 March 2021
|
25 August 2025
|
View |
|
BR-1013
|
Somatropin
|
Norditropin SimpleXx
|
5 mg / 1.5 mL
|
Solution For Injection (SC)
|
-
|
Novo Nordisk A/S
|
Denmark
|
-
|
19 April 2021
|
15 November 2025
|
View |
|
BR-1014
|
Biphasic Insulin Aspart 30
|
NovoMix 30 FlexPen
|
100 IU/ mL
|
Suspension for injection (SC)
|
Antidiabetic
|
Novo Nordisk A/S
|
Denmark
|
Automatic Renewal
|
01 February 2022
|
21 December 2026
|
View |
|
BR-1015
|
Insulin Aspart
|
NovoRapid Flexpen
|
100 IU/ mL
|
Solution For Injection (SC)
|
-
|
Novo Nordisk A/S
|
Denmark
|
-
|
08 March 2021
|
13 August 2025
|
View |
|
BR-1016
|
Liraglutide
|
Victoza
|
6mg/mL
|
Solution For Injection (SC)
|
-
|
Novo Nordisk A/S
|
Denmark
|
-
|
26 November 2021
|
07 February 2026
|
View |
|
BR-1018
|
Darbepoetin Alfa
|
Nesp
|
20mcg/0.5mL
|
Solution For Injection (I.V. / S.C.)
|
-
|
Terumo Corporation (Kofu Factory)
|
Japan
|
Initial
|
09 October 2020
|
26 January 2025
|
View |
|
BR-1019
|
Darbepoetin Alfa
|
Nesp
|
30mcg/0.5mL
|
Solution For Injection (I.V. / S.C.)
|
-
|
Terumo Corporation (Kofu Factory)
|
Japan
|
Initial
|
09 October 2020
|
26 January 2025
|
View |
|
BR-1020
|
Darbepoetin Alfa
|
Nesp
|
40mcg/0.5mL
|
Solution For Injection (I.V./S.C.)
|
-
|
Terumo Corporation (Kofu Factory)
|
Japan
|
Initial
|
09 October 2020
|
26 January 2025
|
View |
|
BR-1025
|
Tetanus Toxoid Adsorbed
|
None
|
40 iu / 0.5mL
|
Suspension for Injection (IM)
|
-
|
Biological E. Limited
|
India
|
-
|
06 March 2020
|
28 January 2025
|